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Background: To evaluate characteristics of venous hemodynamics, together with cardiac and arterial function, in
uncomplicated pregnancies (UP), non-proteinuric gestational hypertension (GH) and preeclampsia (PE).
Methods: In this observational cross-sectional study, venous hemodynamics was assessed using a standardised
protocol for combined electrocardiogram (ECG)-Doppler ultrasonography, together with a non-invasive standardised
cardiovascular assessment using impedance cardiography (ICG) in 13 women with UP, 21 with GH, 34 with late onset
PE ≥ 34 w (LPE) and 22 with early onset PE < 34 w (EPE). ECG-Doppler parameters were impedance index at the level
of hepatic veins (HVI) and renal interlobar veins (RIVI) together with venous pulse transit times (VPTT), as well as resistive
and pulsatility index, and arterial pulse transit time (APTT) at the level of uterine arcuate arteries. ICG parameters were
aortic flow velocity index (VI), acceleration index (ACI) and thoracic fluid content. Mann Whitney U-test, Kruskall-Wallis
test and linear regression analysis with heteroskedastic variance was used for statistical analysis.
Results: RIVI in both kidneys was >15% higher (P≤ .010) in LPE and EPE, as compared to GH and UP. Next to this, >30%
lower values for VI and ACI (P≤ .029), and > 15% lower values for APTT (P≤ .012) were found in GH, LPE and EPE, as
compared to GH.
Conclusion: In comparison to UP, similar abnormalities of central arterial function and APTT were found in GH, EPE and
LPE. Proteinuria of LPE and EPE was associated with increased RIVI, this was not observed in GH.
Keywords: Hemodynamics, Pregnancy, Hypertension, PreeclampsiaBackground
Abnormal arterial tone and increased arterial stiffness are
well known features of preeclampsia [1,2]. This is reflected
in abnormal notching and increased pulsatility index in
duplex ultrasound assessment of the uterine arteries [3]
and in abnormal serum analytes in a subpopulation of
pregnant women destined to develop preeclampsia
[4]. It has been reported that the maternal heart is
subject to morphological and functional changes during
uncomplicated pregnancy [5] and that this cardiac
adaptation is different in women with preeclampsia
[6,7] or destined to develop preeclampsia [8]. Next
to this, it has also been reported that preeclampsia
is associated with venous hemodynamic dysfunction
[9], which is present weeks before clinical onset of* Correspondence: wilfried.gyselaers@zol.be
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preeclampsia [10,11].
Cardiovascular profiling is defined as the integrated
assessment of an individual’s cardiac and vascular
function, which was reported to differ between EPE and
LPE [12]. It has been suggested that the addition of
venous hemodynamic function assessment to the maternal
cardiovascular profile may be useful in the assessment of
women with gestational hypertensive disease [10].
Combined electrocardiogram - Doppler ultrasonography
(ECG-D) [13-15] and impedance cardiography (ICG) are
non-invasive methods to study maternal hemodynamics,
with acceptable reproducibility and repeatability when
applied according to standardized protocols [16-20].
In this study, we used ECG-D evaluation of maternal
arterial and venous hemodynamics, and ICG for assess-
ment of cardiac and arterial function, to evaluate the
cardiovascular profile of women with uncomplicatedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(GH), early- (EPE) or late-onset preeclampsia (LPE).
Methods
Approval of the local Committee for Medical Ethics
was obtained before study onset (MEC ZOL reference
08/049, 09/049 and 09/050). The study was performed
conform the declaration of Helsinki.
Women, admitted between 1/10/2009 and 31/10/2012
to the Fetal Maternal Medicine Unit of Ziekenhuis Oost
Limburg Genk Belgium for gestational hypertensive
disease, were included. For this study, we excluded women
with multiple gestation, essential hypertension, renal
disease, history of organ transplantation, women with
concomitant diseases as diabetes, thyroid dysfunction,
cholestasis, or liver disease, and women with signs of
atypical preeclampsia, such as HELLP syndrome without
proteinuria or with non-hypertensive proteinuria, leaving
for inclusion only those women without known diseases
and new onset hypertension > 20 weeks. Definitions of
gestational hypertension and preeclampsia were used,
according to the criteria of the National High Blood
Pressure Education Program Working Group on High
Blood Pressure in Pregnancy [21]: hypertension is
defined as blood pressure > 140/90 mm Hg on at least 2
occasions at least 6h apart. New onset hypertension > 20
weeks with proteinuria < 300 mg/24h is defined as
gestational hypertension (GH), whereas hypertension
with proteinuria ≥ 300 mg/24h is defined as preeclampsia
(PE). PE < 34 weeks is defined as early onset preeclampsia
(EPE), whereas PE ≥ 34 weeks is defined as late onset
preeclampsia (LPE).
All women had clinical observations for at least 24h,
including blood pressure measurement 3 times a day,
fetal monitoring 1pd, 24h urine sampling for quantitative
assessment of creatinine clearance and proteinuria, and
serum analysis for hemoglobin (Hb) level, hematocrit
(Hct), blood platelet count and concentrations of AST,
ALT and uric acid. After informed consent, all women had
ECG-D investigations in supine position at the level of
hepatic veins (HV), renal interlobar veins (RIV) of both
kidneys, and left and right arcuate uterine arteries as
reported [22], using a 3.5 – 5 MHz probe (Toshiba Aplio
Mx©, Toshiba Medical Systems nv, Sint-Stevens-Woluwe,
Belgium). Uterine arcuate arteries were preferred
over uterine arteries for their intra-parenchymatous
localization, comparable with the localization of hepatic
and renal interlobar veins [15]. The Doppler ultrasound
measurements of the uterine arcuate arteries were
performed within a maximum of 2 cm distance from
the bifurcation at the uterine artery. None of the
subjects were in labor at the time of the investigations.
Doppler investigations were performed by sonographers,
with known inter-observer and intra-observer correlationsof ≥ 0.80. Care was taken to perform as much as pos-
sible all Doppler examinations before the initiation of
antihypertensive therapy.
Maternal Doppler flow parameters were classified as
venous impedance index (RIVI and HVI for RIV and HV
respectively) or arterial resistivity index (RI), defined as
(maximum velocity – minimum velocity)/maximum
velocity. Arterial pulsatility index (PI) was defined as
(maximum velocity – mean velocity)/maximum velocity.
Maternal venous pulse transit times (VPTT) were
defined as the time interval (ms) between the maternal
ECG P-wave and corresponding Doppler A-wave, corrected
for the duration of the corresponding cardiac cycle [14].
Maternal arterial pulse transit time (APTT) was defined as
the time interval (ms) between the maternal ECG Q-wave
and start of Doppler systole, again corrected for the
duration of the corresponding cardiac cycle [15].
Immediately after the Doppler ultrasonography, all
women had Impedance Cardiography (ICG) assessment
in supine and standing position using the Non-Invasive
Continuous Cardiac Output Monitor (NICCOMO©,
Software version 2.0, Medis Medizinische Messtechnik
GmbH, Ilmenau Germany) according to the reported
methodology and protocol with known repeatability [17].
This impedance technique is a non-invasive method of
evaluating haemodynamic parameters, based on thoracic
resistance changes measured during each heart cycle of a
high frequent, low powered electrical current using a set
of 4 skin-electrodes [16,23].
ICG-parameters were classified as pressure parameters,
left ventricular output parameters, aortic flow parameters,
and thoracic fluid content (TFC in 1/kOhm) [16,17].
Pressure parameters were systolic blood pressure
(SBP), diastolic blood pressure (DBP), pulse pressure
(PP = SBP – DBP) and mean blood pressure (MBP =
DBP + PP/3), all expressed in mmHg. Left ventricular
output parameters were stroke volume (SV) in mL, heart
rate (HR) in beats/min and cardiac output in mL/min
(CO=HR × SV). Aortic flow parameters were velocity
index (VI in 1/1000/s) which is equivalent to the amplitude
of the systolic wave, acceleration index (ACI in 1/100/s2)
which stands for the maximum acceleration of blood flow
in the aorta, Heather index (HI in Ohm/s2) in which the
amplitude of the systolic ICG wave is corrected for the
time needed by the ventricle to reach maximum ejection,
and total arterial compliance (TAC in mL/mmHg) which is
calculated as SV/PP and is equivalent for distensibility of
the arterial vascular system [16].
ICG and maternal Doppler flow parameters were also
collected at 38 weeks of gestation in a total of 13 women
with confirmed normal outcome of pregnancy.
All women delivered in Ziekenhuis Oost-Limburg
Genk Belgium, and data on maternal and neonatal
outcome were collected after delivery: maternal age and
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parity, gestational age at observation and delivery (weeks),
birth weight (g) and birth weight percentiles according to
population specific reference values [24].
Data were filled into a database and categorized as (1)
UP, (2) GH, (3) LPE and (4) EPE, and expressed as means
and interquartile ranges. SPSS software version 20.0 was
used for statistical comparison at nominal level α = 0.05,
using Mann–Whitney U-test for comparison between
individual groups and Kruskall-Wallis test for combined
comparison of groups. Significant linear dependence
between clinical, laboratory, ICG and ECG-Doppler vari-
ables was identified using Pearson’s correlation coefficient
(PCC) at nominal level α = 0.05 (two-tailed), and goodness
of fit of the resulting linear regression model was
reported by R2 and corresponding p-value. Correlations
were calculated between VPTT and venous impedance
index for UP, GH, LPE and EPE at the level of HV and
RIV, and compared statistically using linear regression
analysis with heteroskedastic variance (SAS software V9.2).
Results
A total of 90 women were included: 13 with UP, 21 with
GH, 34 with LPE and 22 with EPE.
Table 1 lists the demographic characteristics in the 4
patient groups. Maternal age, BMI, number of smokers
and nulliparity were not different between groups. The
same was true for values of Hb, Hct, platelet count,
AST, ALT, and creatinine clearance. Gestational age atTable 1 Maternal characteristics, pregnancy outcome and lab
UP (n = 13) GH (n = 21)
Maternal
characteristics
Age (years) 31 (28; 32) 32 (30; 36)
BMI 23 (21; 26) 24 (22; 29)
Nulliparity (n, %) 6 (46) 15 (71)





40 (38; 41) 39 (39; 40)
Birth weight (g) 3455 (3180; 3790) 3545 (3120; 37
Birth weight (percentile) 50 (38; 79) 63 (31; 83)
Lab results
Hb (g/dL) / 12.1 (11.4; 13.
Hct (%) / 35.4 (33.6; 38.
Blood platelets (1000/μL) / 193 (152; 227
AST (U/L) / 19 (16; 22)
ALT (U/L) / 12 (10; 14)
UrAc (mmol/L) / 0.129 (0.106; 0.1
Prot24h (mg) / 174 (134; 222
CreatCl (mL/min) / 124 (92; 149
Maternal characteristics, pregnancy outcome and laboratory results in women with
early-onset preeclampsia (LPE and EPE, respectively). BMI = body mass index, Hb = h
ALT = alanin transaminase, UrAc = serum Uric Acid concentration, Prot24h = 24 h prdelivery, birth weight and birth weight percentile were
different between groups, with lowest values for EPE.
Concentrations of serum uric acid and proteinuria were
highest for EPE and lowest for GH. Antihypertensive
medication use in all groups was less than 10%.
Table 2 shows the maternal ICG measurements in the 4
groups, which were measured at 38 (37;40) weeks in UP,
GH and LPE and at 32 (29;34) weeks in EPE. In the gesta-
tional hypertension groups, blood pressures were higher
than in UP as expected, but also aortic flow parameters
ACI, VI and TAC were lower than in UP. Thoracic fluid
content was lower in GH than in other groups.
As shown in Table 3, combined ECG-Doppler renal
VPTT and uterine arcuate APTT, and RIVI, RI and PI
were different between groups, with respectively lowest
and highest values for EPE. Only hepatic VPTT was not
different between groups.
There was a negative correlation between venous
impedance index (HVI and RIVI) and VPTT for all
groups at the level of liver and right kidney. For the left
kidney, however, the negative correlation between RIVI
and VPTT was only true for EPE, but not for UP, GH and
LPE. The difference in slope and correlation between left
kidney EPE and UP, GH or LPE was significant (P ≤ .05).
Figure 1 shows the correlation between venous impedance
index and VPTT for EPE, LPE and GH at the level of liver
(Figure 1A), right (Figure 1B) and left kidneys (Figure 1C).
Figure 2 illustrates the comparison between UP and
GH, between GH and LPE, and between LPE and EPEoratory results
LPE (n = 34) EPE (n = 22) P-value (Kruskall-Wallis)
(UP to EPE)
29 (26; 34) 29 (26; 30) .058
27 (23; 34) 25 (24; 31) .103
28 (82) 17 (77) .088
3 (9) 3 (14) .524
38 (37; 39) 32 (29; 34) <.001
43) 3030 (2749; 3679) 1607 (1176; 1933) <.001
38 (18; 75) 31 (18; 50) .007
3) 11.7 (10.6; 12.5) 12.1 (11.2; 13.2) .248
4) 34.2 (31.9; 36.4) 35.6 (33.1; 36.9) .317
) 183 (165; 256) 178 (142; 218) .632
18 (15; 25) 19 (16; 32) .326
13 (10; 20) 15 (10; 34) .205
63) 0.155 (0.129; 0.178) 0.171 (0.137; 0.199) .014
) 858 (388; 2273) 2254 (899; 5345) <.001
) 125 (97; 155) 119 (91; 152) .898
uncomplicated pregnancy (UP), gestational hypertension (GH), late- and
emoglobin concentration, Hct = hematocrit, AST = aspartate transaminase,
oteinuria, CreatCl = creatinine clearance.
Table 2 Blood pressures and ICG parameters
UP (n = 13) GH (n = 21) LPE (n = 34) EPE (n = 22) P-value (Kruskall-Wallis) (UP to EPE)
Gestational age 38 (38; 39) 38 (37; 39) 38 (36; 39) 32 (30; 34) <.001
Pressures
SBP (mmHg) 124 (117; 132) 150 (138; 161) 155 (141; 168) 155 (145; 172) <.001
DBP (mmHg) 84 (81; 88) 98 (92; 104) 102 (96; 109) 101 (92; 109) <.001
MAP (mmHg) 95 (92; 99) 111 (102; 117) 115 (108; 120) 113 (107; 123) <.001
PP (mmHg) 38 (36; 44) 53 (44; 57) 53 (41; 64) 57 (49; 63) <.001
Left ventricular output
CO (L/min) 7.6 (6.5; 8.9) 7.9 (7.0; 9.4) 8.4 (7.1; 10.3) 7.7 (6.6; 9.1) .359
HR (1/min) 95 (81; 100) 94 (92; 102) 90 (82; 101) 96 (79; 105) .634
SV (mL) 84 (77; 96) 89 (69; 98) 91 (79;114) 85 (68; 95) .352
Aortic flow
VI (1/1,000/s) 67 (50; 69) 44 (41; 61) 44 (36; 54) 46 (34; 61) .018
ACI (1/100/s2) 117 (76; 142) 75 (60; 100) 73 (56; 87) 77 (56; 111) .043
HI (Ohm/s2) 15.5 (10.6; 20.7) 12.3 (10.4; 16.6) 11.1 (7.6; 13.9) 10.9 (6.4; 15.4) .066
TAC (mL/mmHg) 2.1 (1.9; 2.6) 1.6 (1.3; 2.3) 1.7 (1.4; 2.4) 1.5 (1.2; 1.8) .019
Thoracic fluid content TFC (1/kOhm) 31.9 (27.7; 34.9) 27.5 (26.6; 30.2) 32.3 (29.2; 36.0) 34.9 (32.1; 40.6) <0.001
Parameters of maternal cardiovascular function as measured by impedance cardiography (ICG) in uncomplicated pregnancy (UP), gestational hypertension (GH),
late- and early-onset preeclampsia (LPE and EPE, respectively). SBP = systolic blood pressure, DBP = diastolic blood pressure, MAP =mean arterial pressure,
PP = pulse pressure, CO = cardiac output, HR = heart rate, SV = stroke volume, VI = aortic flow velocity index, ACI = aortic flow acceleration index, TAC = total arterial
compliance, TFC = thoracic fluid content.
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hemodynamic function at the level of hepatic, right and
left renal interlobar veins and arterial hemodynamic
function at right and left uterine arcuate arteries.
Aortic flow parameters ACI and VI were lower in the
hypertension groups than in UP, but were not different
between GH, LPE and EPE (Figure 2A). The same was
true for hepatic VPTT (Figure 2B). HVI was higher in
EPE than in the other 3 groups (Figure 2B). RIVI were not
different between UP and GH, or between the hypertension
groups. However, RIVI was higher in the preeclampsiaTable 3 Combined ICG-Doppler parameters
UP (n = 13) GH (n
Gestational age 38 (38; 39) 38 (37
Arterial Resistivity and pulsatility Left RI 0.54 (0.43; 0.60) 0.56 (0.3
Left PI 0.75 (0.55; 0.85) 0.82 (0.4
Right RI 0.60 (0.51; 0.68) 0.46 (0.3
Right PI 0.87 (0.62; 1.05) 0.58 (0.4
Pulse transit time Left APTT 0.36 (0.31; 0.40) 0.30 (0.2
Right APTT 0.39 (0.37; 0.41) 0.30 (0.2
Venous Impedance index Left RIVI 0.40 (0.35; 0.42) 0.35 (0.3
Right RIVI 0.34 (0.30; 0.42) 0.31 (0.2
HVI 0.19 (0.10; 0.60) 0.27 (0.0
Pulse transit time Left VPTT 0.47 (0.42; 0.52) 0.43 (0.3
Right VPTT 0.41 (0.37; 0.50) 0.40 (0.3
Liver VPTT 0.39 (0.34; 0.54) 0.29 (0.2
Combined electrocardiogram (ECG)-Doppler assessment of arterial hemodynamics a
kidney, right kidney and liver. Arterial resistivity index (RI) is defined as (maximum v
impedance index, which at the level of renal interlobar veins is called RIVI, and at th
(maximum velocity – mean velocity)/maximum velocity), VPTT is the venous pulse tgroups than in GH and UP (Figure 2C and D). Uterine
arcuate APTT in GH was shorter than in UP and
higher than in LPE, but not different between PE
groups (Figure 2E and F). Uterine arcuate RI was
higher in EPE than in other groups (Figure 2E and F).
Discussion
From the results of this observational cohort study,
some characteristics of cardiac, arterial and venous
function can be deduced for gestational hypertension,
late-onset preeclampsia and early-onset preeclampsia. In= 21) LPE (n = 34) EPE (n = 22) P-value (Kruskall-Wallis)
(UP to EPE)
; 39) 38 (36; 39) 32 (28; 33) <.001
9; 0.62) 0.56 (0.48; 0.66) 0.75 (0.60; 0.81) .001
9; 0.90) 0.79 (0.63; 1.01) 1.19 (0.84; 1.35) .001
9; 0.56) 0.55 (0.46; 0.61) 0.64 (0.51; 0.78) .005
9; 0.78) 0.77 (0.61; 0.88) 0.94 (0.69; 1.26) .006
8; 0.34) 0.28 (0.23; 0.30) 0.26 (0.22; 0.30) <.001
9; 0.35) 0.28 (0.24; 0.30) 0.26 (0.23; 0.30) <.001
1; 0.43) 0.43 (0.36; 0.47) 0.45 (0.37; 0.53) .010
7; 0.36) 0.38 (0.32; 0.43) 0.44 (0.38; 0.49) .001
8; 0.49) 0.27 (0.15; 0.67) 0.74 (0.23; 1.55) .044
9; 0.45) 0.39 (0.36; 0.45) 0.34 (0.24; 0.45) .003
6; 0.46) 0.38 (0.35; 0.43) 0.34 (0.29; 0.40) .043
1; 0.36) 0.33 (0.22; 0.44) 0.29 (0.19; 0.43) .065
t left and right uterine arcuate arteries and of venous hemodynamics at left
elocity – minimum velocity)/maximum velocity). RI is the equivalent to venous
e level of hepatic veins is called HVI. Arterial pulsatility index is defined as
ransit time and APTT is the arterial pulse transit time.




































0.0 0.2 0.4 0.6 0.8 1.0
RIVI
0.0 0.2 0.4 0.6 0.8 1.0
RIVI
A. Hepatic venous flow
B. Right renal venous flow
C. Left renal venous flow
Figure 1 Correlation between venous pulse transit time and
venous impedance index in liver and kidneys. Venous pulse
transit time (VPTT), venous impedance index in liver (HVI) and
kidneys (RIVI), uncomplicated pregnancies (UP), gestational
hypertension (GH), late-onset preeclampsia (LPE) and early-onset
preeclampsia (EPE), at the level of the liver (panel A), right kidney
(panel B) and left kidney (panel C).
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(1) gestational hypertensive diseases GH, LPE and EPE
show impaired central arterial hemodynamic function as
compared to UP, (2) arterial vascular tone in LPE is higher
than in GH, but lower than in EPE, and (3) compared to
GH, preeclampsia exhibits higher RIVI in association with
proteinuria.Our study is original because it evaluates the global
maternal circulation, including heart, arteries and
veins. The non-invasive methods used have all been
thoroughly evaluated, and reproducibility and repeatability
have been reported. Finally, the patients included in each
group strictly comply with all reported criteria for each
disorder, and are free of interfering maternal or gestational
diseases.
Our study includes for each group a rather limited
number of patients, specifically in the uncomplicated
pregnancy group, which may imply a lack of power to
show significant difference. Next to this, our study does
not allow drawing definitive conclusions on the individual
role of heart, arteries and veins in the development
or the clinical presentation of PE, nor on the role of
the venous compartment in PE-related organ dysfunction.
To evaluate this, more clinical and experimental research
is needed. Finally, the definition of preeclampsia as
proteinuric gestational hypertension, as used in this
paper, is not fully in line with the current definition of the
American College of Obstetricians and Gynecologists’
Task Force on Hypertension in Pregnancy, stating
that proteinuria is not a fundamental prerequisite of
preeclampsia anymore.
Venous hemodynamic dysfunction
Venous hemodynamic dysfunction in PE was reported
for the first time by Bateman et al. [25]. In former publi-
cations, we have reported that RIVI is higher in EPE
than in LPE [9] and that HVI is also increased in PE, as
compared to UP [26]. Current data add to these reports
that both EPE and LPE differ from GH in increased RIVI
(Table 3). Increase of RIVI for both kidneys is associated
with > 300 mg/24 h proteinuria and with increased
serum uric acid concentrations (Table 1). RIVI is defined
as (max velocity – min velocity)/max velocity. Minimum
venous flow velocity has been linked to a sudden
deceleration of forward flow due to the counteractive
force of the right atrial systole, which causes intravenous
backflow into the venous system by lack of valve
between atrium and vena cava [27]. At the level of HV,
this counteraction is responsible for reversal of the venous
A-wave, leading to a triphasic pattern of HV Doppler
waves in PE [26]. At the level of RIV, this counteraction is
responsible for the so-called venous pre-acceleration
nadir (VPAN) in PE, which is rarely seen in UP or in
non-pregnant condition [9]. As such, these observa-
tions illustrate that intravenous backflow from atrial
systole in PE is transported in retrograde direction up
to the level of the renal parenchyma. Our current
data illustrate that RIVI values in EPE and LPE are
higher than in GH, implying that this intrarenal backflow
seems to be an intrinsic feature for PE but not for GH
(Figure 1, Table 3).
Figure 2 Comparison of cardiac, arterial and venous hemodynamic parameters between uncomplicated and hypertensive pregnancies.
Parameters at the level of aorta (panel A), liver (panel B), right kidney (panel C), left kidney (panel D), right uterine arcuate artery (panel E) and
left uterine arcuate artery (panel F). Uncomplicated pregnancy (UP), gestational hypertension (GH), late-onset preeclampsia (LPE) and early-onset
preeclampsia (EPE), VI = aortic flow velocity index, as measured by impedance cardiography (ICG), ACI = ICG-measured aortic flow acceleration
index; HVI = hepatic vein impedance index, RIVI = renal interlobar vein impedance index; VPTT = venous pulse transit time, APTT = arterial pulse
transit time. An asterisk indicates a statistically significant difference at nominal level α≤ 0.05 with Mann–Whitney U test between UP and GH,
between GH and LPE or between LPE and EPE.
Gyselaers et al. BMC Pregnancy and Childbirth 2014, 14:212 Page 6 of 8
http://www.biomedcentral.com/1471-2393/14/212Venous impedance and venous tone
An inverse correlation between venous impedance index
and VPTT is illustrated in Figure 2. Pulse transit time is
considered a measure for vascular tone: in conditions of
increased vascular tone or stiffness, the propulsion wave
is transported faster through the circulation than in
conditions of low vascular tone, and this is responsible
for a shorter time interval between ECG and pulse or
Doppler wave [28-30]. During PE, shorter pulse transit
times have been measured at both the arterial [31] and
venous sides of the circulation [15]. We reported an
increase of VPTT in UP and a reduction in PE, which
correspond with a reduction or increase of venous tone
in normal gestation and PE respectively [15]. Figure 2
illustrates the negative correlation between VPTT and
venous impedance index, which accounts for UP, GH,
LPE and EPE in liver and right kidney, but only for EPEin the left kidney. It is likely that increased venous tone
in PE is associated with a faster and more distant
rebound of atrial contraction throughout the venous
circulation, up to the level of the kidneys. Figure 2
suggests that only in EPE, this rebound reaches the left
kidney, which is more distant from the heart than the
liver and right kidney [27]. As such, increased RIVI, with
or without VPAN, can be considered a reflection of
pulsatile counteraction of forward venous flow from the
kidneys, which intermittently counteracts renal outflow
during each atrial contraction [10]. Obstruction to
renal venous efflux is known to induce proteinuria,
both under experimental conditions [32] as in clinical
syndromes such as renal vein thrombosis [33], the
nutcracker syndrome [34] and the cardiorenal syndrome
[35]. Whether this pulsatile rebound of atrial contraction
is the trigger for renal dysfunction with increase of serum
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should be evaluated in further experimental and clinical
research.
Peripheral arterial hemodynamic dysfunction
Arterial hemodynamic dysfunction in severe preeclampsia
usually presents clinically as overt arterial hypertension,
related to vasoconstriction of smaller peripheral arteries
and increased systemic vascular resistance. This can be
associated with increased stiffness of the larger arteries
[36]. Reduced arterial compliance persists for years in
women who had pregnancies complicated with PE [37]
and predisposes to gestational hypertensive complications
when present before conception [38]. Arterial hypertonia
and serum concentrations of vasoactive agents are
reported to be higher in EPE than LPE, both during
as before clinical onset of disease [3,4,39]. Our data
correlate with this: as illustrated in Table 3, uterine
arcuate arterial RI is higher in EPE than in LPE, which in
turn shows shorter APTT than in GH.
Central arterial hemodynamic function
Aortic flow parameters VI and ACI directly relate to cardiac
systolic function and aortic compliance: the stronger the
ventricular ejection and aortic compliance, the higher
maximum velocity and acceleration of blood flow in the
aorta. Reduced VI and ACI in gestational hypertensive dis-
eases, as measured by ICG (Table 2), can be considered the
results of impaired central arterial hemodynamic function.
Impaired systolic function has been associated with atypical
gestational morphologic remodelling of the heart [40] and
is reported for GH [41], for preterm [42] and for term PE
[7]. This dysfunction also persists for years after PE [43].
Conclusions
The results of this study confirm those of other publications
that cardiac and arterial function is different between gesta-
tional hypertensive diseases and normal pregnancies. Our
study adds to this knowledge that venous hemodynamic
dysfunction in PE is more pronounced than in GH. Because
presence or absence of proteinuria is the fundamental
difference between GH and PE, this venous dysfunction
may perhaps be much more important in the clinical
presentation of PE than currently considered today.
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